investorscraft@gmail.com

Intrinsic ValueMAX Automation SE (MXHN.DE)

Previous Close4.48
Intrinsic Value
Upside potential
Previous Close
4.48

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

MAX Automation SE operates as a diversified industrial automation provider, delivering specialized machinery and integrated software solutions across high-precision manufacturing, raw material processing, and optoelectronic component production. The company serves key industries such as automotive, medical technology, recycling, and aerospace through its segmented business units—bdtronic, Vecoplan, MA micro, AIM Micro, iNDAT, NSM + Juecker, and Elwema. Each segment targets niche automation needs, from robotic assembly systems to optical component manufacturing, positioning MAX Automation as a versatile player in industrial automation. Its market position is reinforced by technological expertise in high-margin applications, particularly in medical and automotive sectors, where precision and reliability are critical. The company’s international footprint, spanning Europe, North America, and China, provides exposure to diversified demand drivers while mitigating regional economic risks. MAX Automation’s ability to customize solutions for complex industrial processes differentiates it from broader competitors, though it faces competition from larger automation firms and regional specialists. Its focus on sustainability-linked sectors, such as recycling and renewable materials processing, aligns with global industrial trends, offering long-term growth potential.

Revenue Profitability And Efficiency

MAX Automation reported revenue of €366.0 million in its latest fiscal year, with net income of €60.5 million, reflecting a robust net margin of approximately 16.5%. The company’s diluted EPS of €1.47 underscores its earnings capacity, though operating cash flow of €9.8 million suggests tighter liquidity relative to net income. Capital expenditures of €12.5 million indicate moderate reinvestment needs, balancing growth and maintenance.

Earnings Power And Capital Efficiency

The company demonstrates strong earnings power, with segment-specific profitability likely driven by higher-margin automation solutions in medical and optoelectronic markets. Capital efficiency appears balanced, with debt levels (€67.2 million) manageable against €9.0 million in cash reserves. The absence of dividends suggests a reinvestment-focused strategy to sustain technological innovation and market expansion.

Balance Sheet And Financial Health

MAX Automation’s balance sheet shows €67.2 million in total debt against €9.0 million in cash, indicating moderate leverage. The net debt position is manageable given its profitability, though liquidity metrics warrant monitoring. The company’s asset-light model, centered on intellectual property and customized systems, supports financial flexibility.

Growth Trends And Dividend Policy

Growth is likely tied to industrial automation adoption, particularly in medical and recycling sectors. The company’s zero-dividend policy prioritizes reinvestment in R&D and acquisitions. Revenue diversification across geographies and industries mitigates cyclical risks, though reliance on automotive and medical end-markets introduces exposure to sector-specific downturns.

Valuation And Market Expectations

With a market cap of €221.1 million, MAX Automation trades at a P/E of approximately 3.7x based on trailing earnings, suggesting undervaluation relative to industrial peers. The negative beta (-0.024) implies low correlation with broader markets, possibly reflecting niche demand drivers. Investors may price in execution risks in scaling its specialized segments.

Strategic Advantages And Outlook

MAX Automation’s niche expertise in high-precision automation and sustainability-aligned solutions provides a competitive edge. Near-term challenges include supply chain volatility and regional demand fluctuations, but long-term prospects are supported by industrial digitization trends. Strategic focus on higher-growth segments like medical technology and recycling could enhance margins and market share.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount